摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3-二氢-1H-吡咯并[3,2-c]吡啶 | 23596-28-3

中文名称
2,3-二氢-1H-吡咯并[3,2-c]吡啶
中文别名
2,3-二氢-1H-吡咯并[3,2-C]吡啶
英文名称
5-Azaindolin
英文别名
2,3-dihydro-1H-pyrrolo[3,2-c]pyridine
2,3-二氢-1H-吡咯并[3,2-c]吡啶化学式
CAS
23596-28-3
化学式
C7H8N2
mdl
MFCD18382584
分子量
120.154
InChiKey
UPZFJNRJKUKWGW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    152-154 °C(Press: 1.5 Torr)
  • 密度:
    1.114±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.285
  • 拓扑面积:
    24.9
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933990090

SDS

SDS:9409f1b8c59ef80b73a1251168cf81d1
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,3-二氢-1H-吡咯并[3,2-c]吡啶 在 palladium on activated charcoal 吡啶N-溴代丁二酰亚胺(NBS)[1,3-双(二苯基膦基)丙烷]二氯化钯(II)氢气二异丁基氢化铝 作用下, 以 乙醚乙醇二氯甲烷N,N-二甲基甲酰胺 为溶剂, 20.0 ℃ 、101.33 kPa 条件下, 反应 54.67h, 生成 (+/-)-1-methyl-7-(2-phenylnaphthyl)-2-pyrrolino[3,2-c]pyridine
    参考文献:
    名称:
    Configurationally Stable Biaryl Analogues of 4-(Dimethylamino)pyridine:  A Novel Class of Chiral Nucleophilic Catalysts
    摘要:
    A short synthetic approach toward a novel class of chiral nucleophilic catalysts, the dissymmetry of which stems from restricted rotation about an Ar-Ar bond, has been developed. The key steps of the synthesis include preparation of a nucleophilic 1-methyl-2-pyrrolino[3,2-c]pyridine core 16 by ortho-lithiation and creation of the biaryl axes via Suzuki cross-coupling reactions. Comparative HPLC studies of racemization for configurationally labile biaryls 31, 38, and 43 containing 1-methyl-2-pyrrolino[3,2-c]pyridine, 4-(dimethylamino)pyridine, and 4-(1-pyrrolidino)pyridine cores, respectively, have demonstrated that a pyrrolidino substituent ortho to the biaryl axis is optimal for slowing Ar-Ar rotation. Biaryls containing all three cores have been shown to retain DMAP-like catalytic activity in the acylation of a hindered alcohol. Biaryls 55 and 56, which are configurationally stable at ambient temperature, have also been prepared via modification of configurationally labile derivatives. Compounds 55 and 56 in optically pure form should provide a useful starting point for studies on catalytic asymmetric acyl transfer using atropisomeric analogues of DMAP.
    DOI:
    10.1021/jo991011h
  • 作为产物:
    参考文献:
    名称:
    Configurationally Stable Biaryl Analogues of 4-(Dimethylamino)pyridine:  A Novel Class of Chiral Nucleophilic Catalysts
    摘要:
    A short synthetic approach toward a novel class of chiral nucleophilic catalysts, the dissymmetry of which stems from restricted rotation about an Ar-Ar bond, has been developed. The key steps of the synthesis include preparation of a nucleophilic 1-methyl-2-pyrrolino[3,2-c]pyridine core 16 by ortho-lithiation and creation of the biaryl axes via Suzuki cross-coupling reactions. Comparative HPLC studies of racemization for configurationally labile biaryls 31, 38, and 43 containing 1-methyl-2-pyrrolino[3,2-c]pyridine, 4-(dimethylamino)pyridine, and 4-(1-pyrrolidino)pyridine cores, respectively, have demonstrated that a pyrrolidino substituent ortho to the biaryl axis is optimal for slowing Ar-Ar rotation. Biaryls containing all three cores have been shown to retain DMAP-like catalytic activity in the acylation of a hindered alcohol. Biaryls 55 and 56, which are configurationally stable at ambient temperature, have also been prepared via modification of configurationally labile derivatives. Compounds 55 and 56 in optically pure form should provide a useful starting point for studies on catalytic asymmetric acyl transfer using atropisomeric analogues of DMAP.
    DOI:
    10.1021/jo991011h
点击查看最新优质反应信息

文献信息

  • Direct Catalytic Asymmetric Mannich-Type Reaction of α- and β-Fluorinated Amides
    作者:Lennart Brewitz、Fernando Arteaga Arteaga、Liang Yin、Kaliyamoorthy Alagiri、Naoya Kumagai、Masakatsu Shibasaki
    DOI:10.1021/jacs.5b11064
    日期:2015.12.23
    emergence of direct enolization protocols providing atom-economical and operationally simple methods to use enolates for stereoselective C-C bond-forming reactions, eliminating the inherent drawback of the preformation of enolates using stoichiometric amounts of reagents. In its infancy, direct enolization relied heavily on the intrinsic acidity of the latent enolates, and the reaction scope was limited
    过去二十年见证了直接烯醇化方案的出现,提供了原子经济且操作简单的方法来使用烯醇化物进行立体选择性 CC 键形成反应,消除了使用化学计量量的试剂预先形成烯醇化物的固有缺点。在其初期,直接烯醇化严重依赖潜在烯醇化物的固有酸性,反应范围仅限于易于烯醇化的酮和醛。该领域的最新进展使开发羧酸衍生物直接烯醇化成为可能,从而提供了合成通用手性构件的快速途径。尽管对富含对映体的含氟小分子的需求不断增长,由于竞争性和主导性的脱氟途径,α-和β-氟化羰基化合物在直接烯醇化化学中被忽略。在此,我们对 α- 和 β-氟官能化 7-氮杂吲哚啉酰胺的直接和高度立体选择性曼尼希型反应进行了全面研究,该反应依赖于软路易斯酸/硬布朗斯台德碱协同催化体系来保证有效的烯醇化,同时抑制不需要的脱氟。该协议有助于为药物化学提供一系列富含对映体的 β-氨基酸的氟化类似物。在此,我们对 α- 和 β-氟官能化 7-氮杂吲哚啉酰胺的直接
  • BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF
    申请人:Revolution Medicines, Inc.
    公开号:US20210139517A1
    公开(公告)日:2021-05-13
    The present disclosure is directed to modulators of SOS1 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.
    本公开涉及SOS1的调节剂及其在治疗疾病中的应用。还公开了包含相同成分的药物组合物。
  • SUBSTITUTED PYRIDOPYRAZINES AS NOVEL SYK INHIBITORS
    申请人:Su Wei-Guo
    公开号:US20140121200A1
    公开(公告)日:2014-05-01
    Provided are pyridopyrazine compounds of formula (1), pharmaceutical compositions thereof and methods of use therefore, wherein R 1 , R 2 , R 3 , R 4 and m are as defined in the specification.
    提供了式(1)的吡啶吡嗪化合物,以及其药物组合物和使用方法,其中R1、R2、R3、R4和m如规范中所定义。
  • NEW BIS-AMIDO PYRIDINES
    申请人:REISER Ulrich
    公开号:US20150057286A1
    公开(公告)日:2015-02-26
    This invention relates to bis-amido pyridines of general formula (I) their use as SMAC mimetics, pharmaceutical compositions containing them, and their use as a medicaments for the treatment and/or prevention of diseases characterized by excessive or abnormal cell proliferation and associated conditions such as cancer. The groups R 1 to R 4 have the meanings given in the claims and in the specification.
    这项发明涉及一般式(I)的双酰胺吡啶,其作为SMAC模拟物的用途,含有它们的药物组合物,以及它们作为治疗和/或预防由细胞过度或异常增殖引起的疾病及相关症状(如癌症)的药物的用途。R1至R4基团的含义如索赔和说明书中所述。
  • Electrophilic Activation of α,β‐Unsaturated Amides: Catalytic Asymmetric Vinylogous Conjugate Addition of Unsaturated γ‐Butyrolactones
    作者:Ming Zhang、Naoya Kumagai、Masakatsu Shibasaki
    DOI:10.1002/chem.201600740
    日期:2016.4.11
    Although catalytic asymmetric conjugate addition reactions have remarkably advanced over the last two decades, the application of less electrophilic α,βunsaturated carboxylic acid derivatives in this useful reaction manifold remains challenging. Herein, we report that α,βunsaturated 7‐azaindoline amides act as reactive electrophiles to participate in catalytic diastereo‐ and enantioselective vinylogous
    尽管在过去的二十年中,催化不对称共轭加成反应取得了显着进展,但在这种有用的反应歧管中应用较少亲电性的α,β-不饱和羧酸衍生物仍然具有挑战性。在此,我们报道了在由软路易斯酸和布朗斯台德碱组成的协同催化剂存在下,α,β-不饱和7-氮杂吲哚啉酰胺作为反应性亲电体,参与γ-丁内酯的催化非对映和对映选择性乙烯基共轭加成反应。在低至1 mol%的催化剂负载下,反应大部分完成,从而以高度立体选择性的方式得到所需的共轭加合物。
查看更多

同类化合物

(4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 骆驼蓬酸 顺-六氢-1H-吡咯并[3,2-B]吡啶-4(2H)-羧酸叔丁基酯 螺哌啶-4,3’-3H吡咯并[2,3-b]吡啶-2’(1’H)-酮 螺[哌啶-4,3'-吡咯并[2,3-B]吡啶]-2'(1'H)-酮盐酸盐 莫西沙星杂质69 苹果酸法米替尼 苯乙胺,a,4-二甲基-b-苯基- 苄基-11氢吡咯并[3,4-B]吡啶 罗沙布林 甲基6-甲酰基-1-甲基-1H-吡咯并[3,2-b]吡啶-2-羧酸酯 甲基5-氰基-1H-吡咯并[2,3-b]吡啶-2-羧酸酯 甲基1H-吡咯并[2,3-B]吡啶-5-甲酸酯 甲基-1-甲氧基-4-吡咯并[3,2-c]吡啶 甲基 5-硝基-1H-吡咯并[2,3-B]吡啶-2-羧酸 环戊二烯并[4,5]吡咯并[2,3-B]吡啶,5,6,7,8-四氢 氧代-(1H-吡咯并[2,3-b]吡啶-3-基)-乙酸甲酯 培西达替尼盐酸盐 培西达替尼 吲嗪 吲哚嗪-6-羧酸乙酯 吲哚嗪-3-甲腈 吲哚嗪-2-羧酸甲酯 吲哚嗪-2-羧酸 叔丁基八氢-1H-吡咯并[2,3-c]吡啶-6-羧酸盐 叔丁基5-溴-7-氯-3-碘-1H-吡咯并[2,3-c]吡啶-1-羧酸盐 叔丁基5-溴-7-氯-1H-吡咯并[2,3-c]吡啶-1-羧酸盐 叔丁基3-甲酰基-5-甲基-1H-吡咯并[2,3-b]吡啶-1-羧酸盐 叔丁基3-(3-羟丙基-1-炔基)-5-甲基-1H-吡咯并[2,3-b]吡啶-1-羧酸盐 叔丁基(5-甲基-1H-吡咯并[2,3-b]吡啶-3-基)氨基甲酸酯 叔丁基((5-氟代-1H-吡咯并[2,3-b]吡啶-4-基)甲基氨基甲酸酯 反式-六氢-1H-吡咯并[3,4-C]吡啶-5(6H)-羧酸叔丁酯 化合物 T28221 八氢吡咯并[3.4-b]吡啶-1-羧酸叔丁酯 八氢吡咯并[3,4-b]吡啶 八氢-吡咯[3,4-C]吡啶-2-甲酸叔丁酯 八氢-6-(苯基甲基)-1H-吡咯并[3,4-b]吡啶-1-羧酸 1,1-二甲基乙酯 八氢-1H-吡咯并[3,4-C]吡啶 二苯基(吡咯并[2,3-b]吡啶-1-基)膦 二乙基1H-吡咯并[2,3B]吡啶-2,6-二甲酸基酯 乙基7-氯-3-甲基-1H-吡咯并[3,2-b]吡啶-2-甲酸基酯 乙基7-氮杂吲哚-4-羧酸酯 乙基4-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)-1H-吡咯并[2,3-b]吡啶-2-羧酸酯 乙基3-氨基-2-吲嗪羧酸酯 乙基1-乙基-1H-吡咯并[3,2-c]吡啶-6-羧酸酯 中氮茚-7-羧酸甲酯 中氮茚-6-羧酸 中氮茚-1-甲酸甲酯 中氮茚-1-甲酸 中氮茚,1-[[4-(3-溴丙氧基)苯基]磺酰]-2-乙基-